Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel
暂无分享，去创建一个
M. Kersten | G. Salles | U. Jaeger | H. Holte | M. Bishop | C. Tam | K. Izutsu | S. Schuster | J. Westin | E. Waller | P. Borchmann | S. Jaglowski | C. Andreadis | I. Fleury | V. Bachanova | S. Mielke | J. Magenau | R. Awasthi | R. Maziarz | L. Eldjerou | P. Corradini | S. R. Foley | Koji Kato | T. Teshima | N. Wagner-Johnston | K. Besien | K. van Besien | R. Tiwari | P. Ho | T. Lawniczek | J. Mcguirk | Michael R. Bishop | Edmund K. Waller | S. J. Schuster | Gilles A. Salles | J. Westin